Triamcinolone Acetonide Concentration of Aqueous Humor after Decanted 20-mg Intravitreal Injection

Ophthalmology

Volumn 116, Issue 7, 2009, Pages 1356-1359

  Cheng, Lingyun ^a   Banker, Alay S ^b   Martin, Michael ^c   Kozak, Igor ^a   Freeman, William R ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b Laser Centre   (India)

^c Intellikine Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ADULT; ANTERIOR EYE CHAMBER; AQUEOUS HUMOR; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG CLEARANCE; DRUG HALF LIFE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ADULT; AQUEOUS HUMOR; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GLUCOCORTICOIDS; HALF-LIFE; HUMANS; INJECTIONS; MALE; MIDDLE AGED; TANDEM MASS SPECTROMETRY; TRIAMCINOLONE ACETONIDE; VITREOUS BODY;

EID: 67649306247     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.01.039     Document Type: Article

References (19)

1. Chaudhary V., Mao A., Hooper P.L., and Sheidow T.G. Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial. Ophthalmology 114 (2007) 2183-2189
2. Lee J., Freeman W.R., Azen S.P., et al. Prospective, randomized clinical trial of intravitreal triamcinolone treatment of neovascular age-related macular degeneration: one-year results. Retina 27 (2007) 1205-1213
3. Jonas J.B., and Rensch F. Decreased retinal vein diameter after intravitreal triamcinolone for retinal vein occlusions. Br J Ophthalmol 91 (2007) 1711-1712
4. Paccola L., Costa R.A., Folgosa M.S., et al. Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study). Br J Ophthalmol 92 (2008) 76-80
5. Choudhry S., and Ghosh S. Intravitreal and posterior subtenon triamcinolone acetonide in idiopathic bilateral uveitic macular oedema. Clin Experiment Ophthalmol 35 (2007) 713-718
6. Tuncer S., Yilmaz S., Urgancioglu M., and Tugal-Tutkun I. Results of intravitreal triamcinolone acetonide (IVTA) injection for the treatment of panuveitis attacks in patients with Behcet disease. J Ocul Pharmacol Ther 23 (2007) 395-401
7. Mason III J.O., Somaiya M.D., and Singh R.J. Intravitreal concentration and clearance of triamcinolone acetonide in nonvitrectomized human eyes. Retina 24 (2004) 900-904
8. Jonas J.B. Intraocular availability of triamcinolone acetonide after intravitreal injection. Am J Ophthalmol 137 (2004) 560-562
9. Beer P.M., Bakri S.J., Singh R.J., et al. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 110 (2003) 681-686
10. Morrison V.L., Koh H.J., Cheng L., et al. Intravitreal toxicity of the Kenalog vehicle (benzyl alcohol) in rabbits. Retina 26 (2006) 339-344
11. Triesence Ambulatory Surgery Center Fact Sheet. http://www.alcon.com/en/docs/ars-Triesence-fact-sheet-asc.pdf Accessed September 2, 2008
12. Kosobucki B.R., Freeman W.R., and Cheng L. Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomised eye. Br J Ophthalmol 90 (2006) 705-708
13. Kamppeter B.A., Cej A., and Jonas J.B. Intraocular concentration of triamcinolone acetonide after intravitreal injection in the rabbit eye. Ophthalmology 115 (2008) 1372-1375
14. Chin H.S., Park T.S., Moon Y.S., and Oh J.H. Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes. Retina 25 (2005) 556-560
15. Davson H. A comparative study of the aqueous humour and cerebrospinal fluid in the rabbit. J Physiol 129 (1955) 111-133
16. Davson H., and Luck C.P. Chemistry and rate of turnover of the ocular fluids of the bush baby (Galago crassicaudatus agisymbanus). J Physiol 145 (1959) 433-439
17. Umland S.P., Nahrebne D.K., Razac S., et al. The inhibitory effects of topically active glucocorticoids on IL-4, IL-5, and interferon-gamma production by cultured primary CD4+ T cells. J Allergy Clin Immunol 100 (1997) 511-519
18. Jaffuel D., Roumestan C., Balaguer P., et al. Correlation between different gene expression assays designed to measure trans-activation potencies of systemic glucocorticoids. Steroids 66 (2001) 597-604
19. Ober M.D., Barile G.R., Tari S.R., et al. Measurement of the actual dose of triamcinolone acetonide delivered by common techniques of intravitreal injection. Am J Ophthalmol 142 (2006) 597-600